Table 1 Trends in relative survival (%) by sex, time since diagnosis and calendar period of diagnosis: England and Wales, adults (15–99 years) diagnosed during 1986–1999 and followed up to 2001

From: Survival from melanoma of the skin in England and Wales up to 2001

  

Calendar period of diagnosis a

    
  

1986–1990

1991–1995

1996–1999

Average change (%) every 5 years b

Prediction c for patients diagnosed during 2000–2001

Time since diagnosis

 

Survival (%)

95% CI

Survival (%)

95% CI

Survival (%)

95% CI

Survival (%)

95% CI

Survival (%)

95% CI

1 year

Men

90.9

(90.1, 91.7)

91.9

(91.2, 92.5)

93.8

(93.1, 94.4)

1.7**

(0.5, 3.0)

93.8

(92.9, 94.6)

 

Women

95.8

(95.3, 96.2)

96.2

(95.8, 96.6)

96.9

(96.5, 97.3)

0.0

(−0.7, 0.8)

96.9

(96.3, 97.4)

5 years

Men

70.6

(69.3, 72.0)

74.4

(73.3, 75.5)

77.9

(76.5, 79.2)

4.0**

(1.6, 6.3)

78.1

(76.5, 79.6)

 

Women

85.2

(84.3, 86.0)

87.3

(86.6, 88.0)

89.5

(88.6, 90.3)

0.3

(−1.2, 1.8)

89.8

(88.7, 90.7)

10 years

Men

64.6

(63.0, 66.1)

69.5

(68.1, 70.9)

  

3.9

(−1.0, 8.9)

73.2

(71.3, 75.0)

 

Women

81.4

(80.4, 82.3)

84.2

(83.2, 85.1)

  

0.9

(−2.3, 4.2)

86.7

(85.4, 87.9)

  1. CI=confidence interval.
  2. aSurvival estimated with cohort or complete approach (see Rachet et al, 2008).
  3. bMean absolute change (%) in survival every 5 years, adjusted for deprivation (see Rachet et al, 2008).
  4. cSurvival estimated with hybrid approach (see Rachet et al, 2008).
  5. **P<0.01.
Back to article page